Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

Clinical trial NCT03368092 · RECRUITING

Trial details

NCT number: NCT03368092
Sponsor: University Hospital, Strasbourg, France
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Trauma Respiratory Distress Syndrome, Adult

Start date: 2019-03-04
Primary completion: 2027-09-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.